2001
DOI: 10.1016/s0022-510x(01)00641-4
|View full text |Cite
|
Sign up to set email alerts
|

Hypoperfusion in the supplementary motor area, dorsolateral prefrontal cortex and insular cortex in Parkinson's disease

Help me understand this report

Search citation statements

Order By: Relevance

Paper Sections

Select...
3
1
1

Citation Types

7
45
0

Year Published

2005
2005
2018
2018

Publication Types

Select...
9

Relationship

0
9

Authors

Journals

citations
Cited by 78 publications
(52 citation statements)
references
References 47 publications
7
45
0
Order By: Relevance
“…Various authors have reported normal flow or only a localized reduction in cerebral perfusion in nondemented patients with PD, and our present results for nondemented PD patients appear consistent with those of previous reports [4,5,23,28,29] in which rCBF was reduced in the parietal or frontal cortex, or the thalamus. Although some investigators have reported that intravenous bolus administration of L-DOPA increases CBF [30], we suspect that our results were little affected by L-DOPA, dopamine agonist, and anticholinergic therapy, since many authors [28,31,32] have reported that cortical blood flow in PD is not affected by the long-term oral administration of these drugs. Perfusion deficits in PDD, DLB, and AD, comparing 3D-SSP of Z-score maps constructed using values normalized to cerebellar perfusion between PDD, DLB, and AD patients and to normal controls.…”
Section: Discussionsupporting
confidence: 93%
“…Various authors have reported normal flow or only a localized reduction in cerebral perfusion in nondemented patients with PD, and our present results for nondemented PD patients appear consistent with those of previous reports [4,5,23,28,29] in which rCBF was reduced in the parietal or frontal cortex, or the thalamus. Although some investigators have reported that intravenous bolus administration of L-DOPA increases CBF [30], we suspect that our results were little affected by L-DOPA, dopamine agonist, and anticholinergic therapy, since many authors [28,31,32] have reported that cortical blood flow in PD is not affected by the long-term oral administration of these drugs. Perfusion deficits in PDD, DLB, and AD, comparing 3D-SSP of Z-score maps constructed using values normalized to cerebellar perfusion between PDD, DLB, and AD patients and to normal controls.…”
Section: Discussionsupporting
confidence: 93%
“…For example, the performance of novelty seeking in patients with PD correlated with the insular cortical dopamine D2 receptor availability [Kaasinen et al, 2004]. In addition, the regional cerebral blood flow (rCBF) in the insula decreases in PD [Hsu et al, 2007;Kikuchi et al, 2001], and is negatively correlated with the motor UPDRS [Hsu et al, 2007]. It has been suggested that the insular hypoperfusion has a relation with disease severity and participates in motor performance, and is consistent with the extended predictions of the basal ganglia circuit model [Hsu et al, 2007].…”
Section: Cmentioning
confidence: 58%
“…[23][24][25][26][27][28][29] Dysfunction of medial frontal areas, which presumably results from altered basal ganglia interactions due to nigrostriatal dopaminergic loss, plays a role in impaired motor performance (ie, hypokinesia). 1,30 This type of functional cortical deafferentation is supported by brain imaging studies showing diminished regional blood flow in the supplementary motor area 24 and the prefrontal region. 23 Morphologic longitudinal imaging studies have shown significant annual brain volume loss in patients with PD without dementia compared with control subjects.…”
Section: Discussionmentioning
confidence: 88%